Other
David Levinthal
Total Trials
3
Recruiting
1
Active
2
Completed
0
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 100/100
Failure Rate
33.3%
1 terminated/withdrawn out of 3 trials
Success Rate
0.0%
-86.5% vs industry average
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
1 of 0 completed trials have results
Key Signals
1 recruiting1 with results
Enrollment Performance
Analytics
N/A
2(66.7%)
Phase 2
1(33.3%)
3Total
N/A(2)
Phase 2(1)
Activity Timeline
Global Presence
Loading network data...
Clinical Trials (3)
Showing 3 of 3 trials
NCT07276035Not ApplicableRecruiting
Brain-Stomach Circuits in Chronic Nausea
Role: lead
NCT03869372Not ApplicableActive Not Recruiting
Cerebral Cortical Influences on Autonomic Function
Role: lead
NCT02609607Phase 2Terminated
Treating Anorectal Dysfunction in MS
Role: lead
All 3 trials loaded